Global Molecular Infectious Disease Testing Market Growth 2025-2031
The global Molecular Infectious Disease Testing market size is predicted to grow from US$ 455 million in 2025 to US$ 624 million in 2031; it is expected to grow at a CAGR of 5.4% from 2025 to 2031.
Molecular Infectious Disease Testing refers to diagnostic tests that detect the genetic material (DNA or RNA) of infectious agents, such as bacteria, viruses, fungi, or parasites, to diagnose an infection. These tests are highly sensitive and can identify pathogens even when they are present in very low quantities, making them crucial for early detection and accurate diagnosis.
United States market for Molecular Infectious Disease Testing is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Molecular Infectious Disease Testing is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Molecular Infectious Disease Testing is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Molecular Infectious Disease Testing players cover Danaher, Roche, bioM?rieux, Hologic, Abbott, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the “Molecular Infectious Disease Testing Industry Forecast” looks at past sales and reviews total world Molecular Infectious Disease Testing sales in 2024, providing a comprehensive analysis by region and market sector of projected Molecular Infectious Disease Testing sales for 2025 through 2031. With Molecular Infectious Disease Testing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Molecular Infectious Disease Testing industry.
This Insight Report provides a comprehensive analysis of the global Molecular Infectious Disease Testing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Molecular Infectious Disease Testing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Molecular Infectious Disease Testing market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Molecular Infectious Disease Testing and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Molecular Infectious Disease Testing.
This report presents a comprehensive overview, market shares, and growth opportunities of Molecular Infectious Disease Testing market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Segmentation by Application:
This report also splits the market by region:
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Key Questions Addressed in this Report
What is the 10-year outlook for the global Molecular Infectious Disease Testing market?
What factors are driving Molecular Infectious Disease Testing market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Molecular Infectious Disease Testing market opportunities vary by end market size?
How does Molecular Infectious Disease Testing break out by Type, by Application?
Molecular Infectious Disease Testing refers to diagnostic tests that detect the genetic material (DNA or RNA) of infectious agents, such as bacteria, viruses, fungi, or parasites, to diagnose an infection. These tests are highly sensitive and can identify pathogens even when they are present in very low quantities, making them crucial for early detection and accurate diagnosis.
United States market for Molecular Infectious Disease Testing is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Molecular Infectious Disease Testing is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Molecular Infectious Disease Testing is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Molecular Infectious Disease Testing players cover Danaher, Roche, bioM?rieux, Hologic, Abbott, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the “Molecular Infectious Disease Testing Industry Forecast” looks at past sales and reviews total world Molecular Infectious Disease Testing sales in 2024, providing a comprehensive analysis by region and market sector of projected Molecular Infectious Disease Testing sales for 2025 through 2031. With Molecular Infectious Disease Testing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Molecular Infectious Disease Testing industry.
This Insight Report provides a comprehensive analysis of the global Molecular Infectious Disease Testing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Molecular Infectious Disease Testing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Molecular Infectious Disease Testing market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Molecular Infectious Disease Testing and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Molecular Infectious Disease Testing.
This report presents a comprehensive overview, market shares, and growth opportunities of Molecular Infectious Disease Testing market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Multiplex Testing
- Singleplex Testing
Segmentation by Application:
- Diagnostic Laboratories
- Hospitals and Clinics
- Others
This report also splits the market by region:
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
- Danaher
- Roche
- bioM?rieux
- Hologic
- Abbott
- Thermo Fisher Scientific
- QIAGEN
- Revvity
- Grifols
- Seegene
- DiaSorin
- Siemens Healthineers
- BD
- QuidelOrtho
- Bruker
- Genetic Signatures
- Co-Diagnostics
- Vela Diagnostics
- Molbio Diagnostics
- Savyon Diagnostics
- Uniogen Oy
- geneOmbio Technologies
- Advanced Molecular Diagnostics
- altona Diagnostics
- GeneFirst
Key Questions Addressed in this Report
What is the 10-year outlook for the global Molecular Infectious Disease Testing market?
What factors are driving Molecular Infectious Disease Testing market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Molecular Infectious Disease Testing market opportunities vary by end market size?
How does Molecular Infectious Disease Testing break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Molecular Infectious Disease Testing Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Molecular Infectious Disease Testing by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Molecular Infectious Disease Testing by Country/Region, 2020, 2024 & 2031
2.2 Molecular Infectious Disease Testing Segment by Type
2.2.1 Multiplex Testing
2.2.2 Singleplex Testing
2.3 Molecular Infectious Disease Testing Sales by Type
2.3.1 Global Molecular Infectious Disease Testing Sales Market Share by Type (2020-2025)
2.3.2 Global Molecular Infectious Disease Testing Revenue and Market Share by Type (2020-2025)
2.3.3 Global Molecular Infectious Disease Testing Sale Price by Type (2020-2025)
2.4 Molecular Infectious Disease Testing Segment by Application
2.4.1 Diagnostic Laboratories
2.4.2 Hospitals and Clinics
2.4.3 Others
2.5 Molecular Infectious Disease Testing Sales by Application
2.5.1 Global Molecular Infectious Disease Testing Sale Market Share by Application (2020-2025)
2.5.2 Global Molecular Infectious Disease Testing Revenue and Market Share by Application (2020-2025)
2.5.3 Global Molecular Infectious Disease Testing Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Molecular Infectious Disease Testing Breakdown Data by Company
3.1.1 Global Molecular Infectious Disease Testing Annual Sales by Company (2020-2025)
3.1.2 Global Molecular Infectious Disease Testing Sales Market Share by Company (2020-2025)
3.2 Global Molecular Infectious Disease Testing Annual Revenue by Company (2020-2025)
3.2.1 Global Molecular Infectious Disease Testing Revenue by Company (2020-2025)
3.2.2 Global Molecular Infectious Disease Testing Revenue Market Share by Company (2020-2025)
3.3 Global Molecular Infectious Disease Testing Sale Price by Company
3.4 Key Manufacturers Molecular Infectious Disease Testing Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Molecular Infectious Disease Testing Product Location Distribution
3.4.2 Players Molecular Infectious Disease Testing Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR MOLECULAR INFECTIOUS DISEASE TESTING BY GEOGRAPHIC REGION
4.1 World Historic Molecular Infectious Disease Testing Market Size by Geographic Region (2020-2025)
4.1.1 Global Molecular Infectious Disease Testing Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Molecular Infectious Disease Testing Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Molecular Infectious Disease Testing Market Size by Country/Region (2020-2025)
4.2.1 Global Molecular Infectious Disease Testing Annual Sales by Country/Region (2020-2025)
4.2.2 Global Molecular Infectious Disease Testing Annual Revenue by Country/Region (2020-2025)
4.3 Americas Molecular Infectious Disease Testing Sales Growth
4.4 APAC Molecular Infectious Disease Testing Sales Growth
4.5 Europe Molecular Infectious Disease Testing Sales Growth
4.6 Middle East & Africa Molecular Infectious Disease Testing Sales Growth
5 AMERICAS
5.1 Americas Molecular Infectious Disease Testing Sales by Country
5.1.1 Americas Molecular Infectious Disease Testing Sales by Country (2020-2025)
5.1.2 Americas Molecular Infectious Disease Testing Revenue by Country (2020-2025)
5.2 Americas Molecular Infectious Disease Testing Sales by Type (2020-2025)
5.3 Americas Molecular Infectious Disease Testing Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Molecular Infectious Disease Testing Sales by Region
6.1.1 APAC Molecular Infectious Disease Testing Sales by Region (2020-2025)
6.1.2 APAC Molecular Infectious Disease Testing Revenue by Region (2020-2025)
6.2 APAC Molecular Infectious Disease Testing Sales by Type (2020-2025)
6.3 APAC Molecular Infectious Disease Testing Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Molecular Infectious Disease Testing by Country
7.1.1 Europe Molecular Infectious Disease Testing Sales by Country (2020-2025)
7.1.2 Europe Molecular Infectious Disease Testing Revenue by Country (2020-2025)
7.2 Europe Molecular Infectious Disease Testing Sales by Type (2020-2025)
7.3 Europe Molecular Infectious Disease Testing Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Molecular Infectious Disease Testing by Country
8.1.1 Middle East & Africa Molecular Infectious Disease Testing Sales by Country (2020-2025)
8.1.2 Middle East & Africa Molecular Infectious Disease Testing Revenue by Country (2020-2025)
8.2 Middle East & Africa Molecular Infectious Disease Testing Sales by Type (2020-2025)
8.3 Middle East & Africa Molecular Infectious Disease Testing Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Molecular Infectious Disease Testing
10.3 Manufacturing Process Analysis of Molecular Infectious Disease Testing
10.4 Industry Chain Structure of Molecular Infectious Disease Testing
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Molecular Infectious Disease Testing Distributors
11.3 Molecular Infectious Disease Testing Customer
12 WORLD FORECAST REVIEW FOR MOLECULAR INFECTIOUS DISEASE TESTING BY GEOGRAPHIC REGION
12.1 Global Molecular Infectious Disease Testing Market Size Forecast by Region
12.1.1 Global Molecular Infectious Disease Testing Forecast by Region (2026-2031)
12.1.2 Global Molecular Infectious Disease Testing Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Molecular Infectious Disease Testing Forecast by Type (2026-2031)
12.7 Global Molecular Infectious Disease Testing Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Danaher
13.1.1 Danaher Company Information
13.1.2 Danaher Molecular Infectious Disease Testing Product Portfolios and Specifications
13.1.3 Danaher Molecular Infectious Disease Testing Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Danaher Main Business Overview
13.1.5 Danaher Latest Developments
13.2 Roche
13.2.1 Roche Company Information
13.2.2 Roche Molecular Infectious Disease Testing Product Portfolios and Specifications
13.2.3 Roche Molecular Infectious Disease Testing Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Roche Main Business Overview
13.2.5 Roche Latest Developments
13.3 bioM?rieux
13.3.1 bioM?rieux Company Information
13.3.2 bioM?rieux Molecular Infectious Disease Testing Product Portfolios and Specifications
13.3.3 bioM?rieux Molecular Infectious Disease Testing Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 bioM?rieux Main Business Overview
13.3.5 bioM?rieux Latest Developments
13.4 Hologic
13.4.1 Hologic Company Information
13.4.2 Hologic Molecular Infectious Disease Testing Product Portfolios and Specifications
13.4.3 Hologic Molecular Infectious Disease Testing Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Hologic Main Business Overview
13.4.5 Hologic Latest Developments
13.5 Abbott
13.5.1 Abbott Company Information
13.5.2 Abbott Molecular Infectious Disease Testing Product Portfolios and Specifications
13.5.3 Abbott Molecular Infectious Disease Testing Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Abbott Main Business Overview
13.5.5 Abbott Latest Developments
13.6 Thermo Fisher Scientific
13.6.1 Thermo Fisher Scientific Company Information
13.6.2 Thermo Fisher Scientific Molecular Infectious Disease Testing Product Portfolios and Specifications
13.6.3 Thermo Fisher Scientific Molecular Infectious Disease Testing Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Thermo Fisher Scientific Main Business Overview
13.6.5 Thermo Fisher Scientific Latest Developments
13.7 QIAGEN
13.7.1 QIAGEN Company Information
13.7.2 QIAGEN Molecular Infectious Disease Testing Product Portfolios and Specifications
13.7.3 QIAGEN Molecular Infectious Disease Testing Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 QIAGEN Main Business Overview
13.7.5 QIAGEN Latest Developments
13.8 Revvity
13.8.1 Revvity Company Information
13.8.2 Revvity Molecular Infectious Disease Testing Product Portfolios and Specifications
13.8.3 Revvity Molecular Infectious Disease Testing Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Revvity Main Business Overview
13.8.5 Revvity Latest Developments
13.9 Grifols
13.9.1 Grifols Company Information
13.9.2 Grifols Molecular Infectious Disease Testing Product Portfolios and Specifications
13.9.3 Grifols Molecular Infectious Disease Testing Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Grifols Main Business Overview
13.9.5 Grifols Latest Developments
13.10 Seegene
13.10.1 Seegene Company Information
13.10.2 Seegene Molecular Infectious Disease Testing Product Portfolios and Specifications
13.10.3 Seegene Molecular Infectious Disease Testing Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Seegene Main Business Overview
13.10.5 Seegene Latest Developments
13.11 DiaSorin
13.11.1 DiaSorin Company Information
13.11.2 DiaSorin Molecular Infectious Disease Testing Product Portfolios and Specifications
13.11.3 DiaSorin Molecular Infectious Disease Testing Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 DiaSorin Main Business Overview
13.11.5 DiaSorin Latest Developments
13.12 Siemens Healthineers
13.12.1 Siemens Healthineers Company Information
13.12.2 Siemens Healthineers Molecular Infectious Disease Testing Product Portfolios and Specifications
13.12.3 Siemens Healthineers Molecular Infectious Disease Testing Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Siemens Healthineers Main Business Overview
13.12.5 Siemens Healthineers Latest Developments
13.13 BD
13.13.1 BD Company Information
13.13.2 BD Molecular Infectious Disease Testing Product Portfolios and Specifications
13.13.3 BD Molecular Infectious Disease Testing Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 BD Main Business Overview
13.13.5 BD Latest Developments
13.14 QuidelOrtho
13.14.1 QuidelOrtho Company Information
13.14.2 QuidelOrtho Molecular Infectious Disease Testing Product Portfolios and Specifications
13.14.3 QuidelOrtho Molecular Infectious Disease Testing Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 QuidelOrtho Main Business Overview
13.14.5 QuidelOrtho Latest Developments
13.15 Bruker
13.15.1 Bruker Company Information
13.15.2 Bruker Molecular Infectious Disease Testing Product Portfolios and Specifications
13.15.3 Bruker Molecular Infectious Disease Testing Sales, Revenue, Price and Gross Margin (2020-2025)
13.15.4 Bruker Main Business Overview
13.15.5 Bruker Latest Developments
13.16 Genetic Signatures
13.16.1 Genetic Signatures Company Information
13.16.2 Genetic Signatures Molecular Infectious Disease Testing Product Portfolios and Specifications
13.16.3 Genetic Signatures Molecular Infectious Disease Testing Sales, Revenue, Price and Gross Margin (2020-2025)
13.16.4 Genetic Signatures Main Business Overview
13.16.5 Genetic Signatures Latest Developments
13.17 Co-Diagnostics
13.17.1 Co-Diagnostics Company Information
13.17.2 Co-Diagnostics Molecular Infectious Disease Testing Product Portfolios and Specifications
13.17.3 Co-Diagnostics Molecular Infectious Disease Testing Sales, Revenue, Price and Gross Margin (2020-2025)
13.17.4 Co-Diagnostics Main Business Overview
13.17.5 Co-Diagnostics Latest Developments
13.18 Vela Diagnostics
13.18.1 Vela Diagnostics Company Information
13.18.2 Vela Diagnostics Molecular Infectious Disease Testing Product Portfolios and Specifications
13.18.3 Vela Diagnostics Molecular Infectious Disease Testing Sales, Revenue, Price and Gross Margin (2020-2025)
13.18.4 Vela Diagnostics Main Business Overview
13.18.5 Vela Diagnostics Latest Developments
13.19 Molbio Diagnostics
13.19.1 Molbio Diagnostics Company Information
13.19.2 Molbio Diagnostics Molecular Infectious Disease Testing Product Portfolios and Specifications
13.19.3 Molbio Diagnostics Molecular Infectious Disease Testing Sales, Revenue, Price and Gross Margin (2020-2025)
13.19.4 Molbio Diagnostics Main Business Overview
13.19.5 Molbio Diagnostics Latest Developments
13.20 Savyon Diagnostics
13.20.1 Savyon Diagnostics Company Information
13.20.2 Savyon Diagnostics Molecular Infectious Disease Testing Product Portfolios and Specifications
13.20.3 Savyon Diagnostics Molecular Infectious Disease Testing Sales, Revenue, Price and Gross Margin (2020-2025)
13.20.4 Savyon Diagnostics Main Business Overview
13.20.5 Savyon Diagnostics Latest Developments
13.21 Uniogen Oy
13.21.1 Uniogen Oy Company Information
13.21.2 Uniogen Oy Molecular Infectious Disease Testing Product Portfolios and Specifications
13.21.3 Uniogen Oy Molecular Infectious Disease Testing Sales, Revenue, Price and Gross Margin (2020-2025)
13.21.4 Uniogen Oy Main Business Overview
13.21.5 Uniogen Oy Latest Developments
13.22 geneOmbio Technologies
13.22.1 geneOmbio Technologies Company Information
13.22.2 geneOmbio Technologies Molecular Infectious Disease Testing Product Portfolios and Specifications
13.22.3 geneOmbio Technologies Molecular Infectious Disease Testing Sales, Revenue, Price and Gross Margin (2020-2025)
13.22.4 geneOmbio Technologies Main Business Overview
13.22.5 geneOmbio Technologies Latest Developments
13.23 Advanced Molecular Diagnostics
13.23.1 Advanced Molecular Diagnostics Company Information
13.23.2 Advanced Molecular Diagnostics Molecular Infectious Disease Testing Product Portfolios and Specifications
13.23.3 Advanced Molecular Diagnostics Molecular Infectious Disease Testing Sales, Revenue, Price and Gross Margin (2020-2025)
13.23.4 Advanced Molecular Diagnostics Main Business Overview
13.23.5 Advanced Molecular Diagnostics Latest Developments
13.24 altona Diagnostics
13.24.1 altona Diagnostics Company Information
13.24.2 altona Diagnostics Molecular Infectious Disease Testing Product Portfolios and Specifications
13.24.3 altona Diagnostics Molecular Infectious Disease Testing Sales, Revenue, Price and Gross Margin (2020-2025)
13.24.4 altona Diagnostics Main Business Overview
13.24.5 altona Diagnostics Latest Developments
13.25 GeneFirst
13.25.1 GeneFirst Company Information
13.25.2 GeneFirst Molecular Infectious Disease Testing Product Portfolios and Specifications
13.25.3 GeneFirst Molecular Infectious Disease Testing Sales, Revenue, Price and Gross Margin (2020-2025)
13.25.4 GeneFirst Main Business Overview
13.25.5 GeneFirst Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Molecular Infectious Disease Testing Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Molecular Infectious Disease Testing by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Molecular Infectious Disease Testing by Country/Region, 2020, 2024 & 2031
2.2 Molecular Infectious Disease Testing Segment by Type
2.2.1 Multiplex Testing
2.2.2 Singleplex Testing
2.3 Molecular Infectious Disease Testing Sales by Type
2.3.1 Global Molecular Infectious Disease Testing Sales Market Share by Type (2020-2025)
2.3.2 Global Molecular Infectious Disease Testing Revenue and Market Share by Type (2020-2025)
2.3.3 Global Molecular Infectious Disease Testing Sale Price by Type (2020-2025)
2.4 Molecular Infectious Disease Testing Segment by Application
2.4.1 Diagnostic Laboratories
2.4.2 Hospitals and Clinics
2.4.3 Others
2.5 Molecular Infectious Disease Testing Sales by Application
2.5.1 Global Molecular Infectious Disease Testing Sale Market Share by Application (2020-2025)
2.5.2 Global Molecular Infectious Disease Testing Revenue and Market Share by Application (2020-2025)
2.5.3 Global Molecular Infectious Disease Testing Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Molecular Infectious Disease Testing Breakdown Data by Company
3.1.1 Global Molecular Infectious Disease Testing Annual Sales by Company (2020-2025)
3.1.2 Global Molecular Infectious Disease Testing Sales Market Share by Company (2020-2025)
3.2 Global Molecular Infectious Disease Testing Annual Revenue by Company (2020-2025)
3.2.1 Global Molecular Infectious Disease Testing Revenue by Company (2020-2025)
3.2.2 Global Molecular Infectious Disease Testing Revenue Market Share by Company (2020-2025)
3.3 Global Molecular Infectious Disease Testing Sale Price by Company
3.4 Key Manufacturers Molecular Infectious Disease Testing Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Molecular Infectious Disease Testing Product Location Distribution
3.4.2 Players Molecular Infectious Disease Testing Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR MOLECULAR INFECTIOUS DISEASE TESTING BY GEOGRAPHIC REGION
4.1 World Historic Molecular Infectious Disease Testing Market Size by Geographic Region (2020-2025)
4.1.1 Global Molecular Infectious Disease Testing Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Molecular Infectious Disease Testing Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Molecular Infectious Disease Testing Market Size by Country/Region (2020-2025)
4.2.1 Global Molecular Infectious Disease Testing Annual Sales by Country/Region (2020-2025)
4.2.2 Global Molecular Infectious Disease Testing Annual Revenue by Country/Region (2020-2025)
4.3 Americas Molecular Infectious Disease Testing Sales Growth
4.4 APAC Molecular Infectious Disease Testing Sales Growth
4.5 Europe Molecular Infectious Disease Testing Sales Growth
4.6 Middle East & Africa Molecular Infectious Disease Testing Sales Growth
5 AMERICAS
5.1 Americas Molecular Infectious Disease Testing Sales by Country
5.1.1 Americas Molecular Infectious Disease Testing Sales by Country (2020-2025)
5.1.2 Americas Molecular Infectious Disease Testing Revenue by Country (2020-2025)
5.2 Americas Molecular Infectious Disease Testing Sales by Type (2020-2025)
5.3 Americas Molecular Infectious Disease Testing Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Molecular Infectious Disease Testing Sales by Region
6.1.1 APAC Molecular Infectious Disease Testing Sales by Region (2020-2025)
6.1.2 APAC Molecular Infectious Disease Testing Revenue by Region (2020-2025)
6.2 APAC Molecular Infectious Disease Testing Sales by Type (2020-2025)
6.3 APAC Molecular Infectious Disease Testing Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Molecular Infectious Disease Testing by Country
7.1.1 Europe Molecular Infectious Disease Testing Sales by Country (2020-2025)
7.1.2 Europe Molecular Infectious Disease Testing Revenue by Country (2020-2025)
7.2 Europe Molecular Infectious Disease Testing Sales by Type (2020-2025)
7.3 Europe Molecular Infectious Disease Testing Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Molecular Infectious Disease Testing by Country
8.1.1 Middle East & Africa Molecular Infectious Disease Testing Sales by Country (2020-2025)
8.1.2 Middle East & Africa Molecular Infectious Disease Testing Revenue by Country (2020-2025)
8.2 Middle East & Africa Molecular Infectious Disease Testing Sales by Type (2020-2025)
8.3 Middle East & Africa Molecular Infectious Disease Testing Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Molecular Infectious Disease Testing
10.3 Manufacturing Process Analysis of Molecular Infectious Disease Testing
10.4 Industry Chain Structure of Molecular Infectious Disease Testing
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Molecular Infectious Disease Testing Distributors
11.3 Molecular Infectious Disease Testing Customer
12 WORLD FORECAST REVIEW FOR MOLECULAR INFECTIOUS DISEASE TESTING BY GEOGRAPHIC REGION
12.1 Global Molecular Infectious Disease Testing Market Size Forecast by Region
12.1.1 Global Molecular Infectious Disease Testing Forecast by Region (2026-2031)
12.1.2 Global Molecular Infectious Disease Testing Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Molecular Infectious Disease Testing Forecast by Type (2026-2031)
12.7 Global Molecular Infectious Disease Testing Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Danaher
13.1.1 Danaher Company Information
13.1.2 Danaher Molecular Infectious Disease Testing Product Portfolios and Specifications
13.1.3 Danaher Molecular Infectious Disease Testing Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Danaher Main Business Overview
13.1.5 Danaher Latest Developments
13.2 Roche
13.2.1 Roche Company Information
13.2.2 Roche Molecular Infectious Disease Testing Product Portfolios and Specifications
13.2.3 Roche Molecular Infectious Disease Testing Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Roche Main Business Overview
13.2.5 Roche Latest Developments
13.3 bioM?rieux
13.3.1 bioM?rieux Company Information
13.3.2 bioM?rieux Molecular Infectious Disease Testing Product Portfolios and Specifications
13.3.3 bioM?rieux Molecular Infectious Disease Testing Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 bioM?rieux Main Business Overview
13.3.5 bioM?rieux Latest Developments
13.4 Hologic
13.4.1 Hologic Company Information
13.4.2 Hologic Molecular Infectious Disease Testing Product Portfolios and Specifications
13.4.3 Hologic Molecular Infectious Disease Testing Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Hologic Main Business Overview
13.4.5 Hologic Latest Developments
13.5 Abbott
13.5.1 Abbott Company Information
13.5.2 Abbott Molecular Infectious Disease Testing Product Portfolios and Specifications
13.5.3 Abbott Molecular Infectious Disease Testing Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Abbott Main Business Overview
13.5.5 Abbott Latest Developments
13.6 Thermo Fisher Scientific
13.6.1 Thermo Fisher Scientific Company Information
13.6.2 Thermo Fisher Scientific Molecular Infectious Disease Testing Product Portfolios and Specifications
13.6.3 Thermo Fisher Scientific Molecular Infectious Disease Testing Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Thermo Fisher Scientific Main Business Overview
13.6.5 Thermo Fisher Scientific Latest Developments
13.7 QIAGEN
13.7.1 QIAGEN Company Information
13.7.2 QIAGEN Molecular Infectious Disease Testing Product Portfolios and Specifications
13.7.3 QIAGEN Molecular Infectious Disease Testing Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 QIAGEN Main Business Overview
13.7.5 QIAGEN Latest Developments
13.8 Revvity
13.8.1 Revvity Company Information
13.8.2 Revvity Molecular Infectious Disease Testing Product Portfolios and Specifications
13.8.3 Revvity Molecular Infectious Disease Testing Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Revvity Main Business Overview
13.8.5 Revvity Latest Developments
13.9 Grifols
13.9.1 Grifols Company Information
13.9.2 Grifols Molecular Infectious Disease Testing Product Portfolios and Specifications
13.9.3 Grifols Molecular Infectious Disease Testing Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Grifols Main Business Overview
13.9.5 Grifols Latest Developments
13.10 Seegene
13.10.1 Seegene Company Information
13.10.2 Seegene Molecular Infectious Disease Testing Product Portfolios and Specifications
13.10.3 Seegene Molecular Infectious Disease Testing Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Seegene Main Business Overview
13.10.5 Seegene Latest Developments
13.11 DiaSorin
13.11.1 DiaSorin Company Information
13.11.2 DiaSorin Molecular Infectious Disease Testing Product Portfolios and Specifications
13.11.3 DiaSorin Molecular Infectious Disease Testing Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 DiaSorin Main Business Overview
13.11.5 DiaSorin Latest Developments
13.12 Siemens Healthineers
13.12.1 Siemens Healthineers Company Information
13.12.2 Siemens Healthineers Molecular Infectious Disease Testing Product Portfolios and Specifications
13.12.3 Siemens Healthineers Molecular Infectious Disease Testing Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Siemens Healthineers Main Business Overview
13.12.5 Siemens Healthineers Latest Developments
13.13 BD
13.13.1 BD Company Information
13.13.2 BD Molecular Infectious Disease Testing Product Portfolios and Specifications
13.13.3 BD Molecular Infectious Disease Testing Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 BD Main Business Overview
13.13.5 BD Latest Developments
13.14 QuidelOrtho
13.14.1 QuidelOrtho Company Information
13.14.2 QuidelOrtho Molecular Infectious Disease Testing Product Portfolios and Specifications
13.14.3 QuidelOrtho Molecular Infectious Disease Testing Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 QuidelOrtho Main Business Overview
13.14.5 QuidelOrtho Latest Developments
13.15 Bruker
13.15.1 Bruker Company Information
13.15.2 Bruker Molecular Infectious Disease Testing Product Portfolios and Specifications
13.15.3 Bruker Molecular Infectious Disease Testing Sales, Revenue, Price and Gross Margin (2020-2025)
13.15.4 Bruker Main Business Overview
13.15.5 Bruker Latest Developments
13.16 Genetic Signatures
13.16.1 Genetic Signatures Company Information
13.16.2 Genetic Signatures Molecular Infectious Disease Testing Product Portfolios and Specifications
13.16.3 Genetic Signatures Molecular Infectious Disease Testing Sales, Revenue, Price and Gross Margin (2020-2025)
13.16.4 Genetic Signatures Main Business Overview
13.16.5 Genetic Signatures Latest Developments
13.17 Co-Diagnostics
13.17.1 Co-Diagnostics Company Information
13.17.2 Co-Diagnostics Molecular Infectious Disease Testing Product Portfolios and Specifications
13.17.3 Co-Diagnostics Molecular Infectious Disease Testing Sales, Revenue, Price and Gross Margin (2020-2025)
13.17.4 Co-Diagnostics Main Business Overview
13.17.5 Co-Diagnostics Latest Developments
13.18 Vela Diagnostics
13.18.1 Vela Diagnostics Company Information
13.18.2 Vela Diagnostics Molecular Infectious Disease Testing Product Portfolios and Specifications
13.18.3 Vela Diagnostics Molecular Infectious Disease Testing Sales, Revenue, Price and Gross Margin (2020-2025)
13.18.4 Vela Diagnostics Main Business Overview
13.18.5 Vela Diagnostics Latest Developments
13.19 Molbio Diagnostics
13.19.1 Molbio Diagnostics Company Information
13.19.2 Molbio Diagnostics Molecular Infectious Disease Testing Product Portfolios and Specifications
13.19.3 Molbio Diagnostics Molecular Infectious Disease Testing Sales, Revenue, Price and Gross Margin (2020-2025)
13.19.4 Molbio Diagnostics Main Business Overview
13.19.5 Molbio Diagnostics Latest Developments
13.20 Savyon Diagnostics
13.20.1 Savyon Diagnostics Company Information
13.20.2 Savyon Diagnostics Molecular Infectious Disease Testing Product Portfolios and Specifications
13.20.3 Savyon Diagnostics Molecular Infectious Disease Testing Sales, Revenue, Price and Gross Margin (2020-2025)
13.20.4 Savyon Diagnostics Main Business Overview
13.20.5 Savyon Diagnostics Latest Developments
13.21 Uniogen Oy
13.21.1 Uniogen Oy Company Information
13.21.2 Uniogen Oy Molecular Infectious Disease Testing Product Portfolios and Specifications
13.21.3 Uniogen Oy Molecular Infectious Disease Testing Sales, Revenue, Price and Gross Margin (2020-2025)
13.21.4 Uniogen Oy Main Business Overview
13.21.5 Uniogen Oy Latest Developments
13.22 geneOmbio Technologies
13.22.1 geneOmbio Technologies Company Information
13.22.2 geneOmbio Technologies Molecular Infectious Disease Testing Product Portfolios and Specifications
13.22.3 geneOmbio Technologies Molecular Infectious Disease Testing Sales, Revenue, Price and Gross Margin (2020-2025)
13.22.4 geneOmbio Technologies Main Business Overview
13.22.5 geneOmbio Technologies Latest Developments
13.23 Advanced Molecular Diagnostics
13.23.1 Advanced Molecular Diagnostics Company Information
13.23.2 Advanced Molecular Diagnostics Molecular Infectious Disease Testing Product Portfolios and Specifications
13.23.3 Advanced Molecular Diagnostics Molecular Infectious Disease Testing Sales, Revenue, Price and Gross Margin (2020-2025)
13.23.4 Advanced Molecular Diagnostics Main Business Overview
13.23.5 Advanced Molecular Diagnostics Latest Developments
13.24 altona Diagnostics
13.24.1 altona Diagnostics Company Information
13.24.2 altona Diagnostics Molecular Infectious Disease Testing Product Portfolios and Specifications
13.24.3 altona Diagnostics Molecular Infectious Disease Testing Sales, Revenue, Price and Gross Margin (2020-2025)
13.24.4 altona Diagnostics Main Business Overview
13.24.5 altona Diagnostics Latest Developments
13.25 GeneFirst
13.25.1 GeneFirst Company Information
13.25.2 GeneFirst Molecular Infectious Disease Testing Product Portfolios and Specifications
13.25.3 GeneFirst Molecular Infectious Disease Testing Sales, Revenue, Price and Gross Margin (2020-2025)
13.25.4 GeneFirst Main Business Overview
13.25.5 GeneFirst Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Molecular Infectious Disease Testing Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Molecular Infectious Disease Testing Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Multiplex Testing
Table 4. Major Players of Singleplex Testing
Table 5. Global Molecular Infectious Disease Testing Sales by Type (2020-2025) & (K Units)
Table 6. Global Molecular Infectious Disease Testing Sales Market Share by Type (2020-2025)
Table 7. Global Molecular Infectious Disease Testing Revenue by Type (2020-2025) & ($ million)
Table 8. Global Molecular Infectious Disease Testing Revenue Market Share by Type (2020-2025)
Table 9. Global Molecular Infectious Disease Testing Sale Price by Type (2020-2025) & (US$/Unit)
Table 10. Global Molecular Infectious Disease Testing Sale by Application (2020-2025) & (K Units)
Table 11. Global Molecular Infectious Disease Testing Sale Market Share by Application (2020-2025)
Table 12. Global Molecular Infectious Disease Testing Revenue by Application (2020-2025) & ($ million)
Table 13. Global Molecular Infectious Disease Testing Revenue Market Share by Application (2020-2025)
Table 14. Global Molecular Infectious Disease Testing Sale Price by Application (2020-2025) & (US$/Unit)
Table 15. Global Molecular Infectious Disease Testing Sales by Company (2020-2025) & (K Units)
Table 16. Global Molecular Infectious Disease Testing Sales Market Share by Company (2020-2025)
Table 17. Global Molecular Infectious Disease Testing Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Molecular Infectious Disease Testing Revenue Market Share by Company (2020-2025)
Table 19. Global Molecular Infectious Disease Testing Sale Price by Company (2020-2025) & (US$/Unit)
Table 20. Key Manufacturers Molecular Infectious Disease Testing Producing Area Distribution and Sales Area
Table 21. Players Molecular Infectious Disease Testing Products Offered
Table 22. Molecular Infectious Disease Testing Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Molecular Infectious Disease Testing Sales by Geographic Region (2020-2025) & (K Units)
Table 26. Global Molecular Infectious Disease Testing Sales Market Share Geographic Region (2020-2025)
Table 27. Global Molecular Infectious Disease Testing Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Molecular Infectious Disease Testing Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Molecular Infectious Disease Testing Sales by Country/Region (2020-2025) & (K Units)
Table 30. Global Molecular Infectious Disease Testing Sales Market Share by Country/Region (2020-2025)
Table 31. Global Molecular Infectious Disease Testing Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Molecular Infectious Disease Testing Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Molecular Infectious Disease Testing Sales by Country (2020-2025) & (K Units)
Table 34. Americas Molecular Infectious Disease Testing Sales Market Share by Country (2020-2025)
Table 35. Americas Molecular Infectious Disease Testing Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Molecular Infectious Disease Testing Sales by Type (2020-2025) & (K Units)
Table 37. Americas Molecular Infectious Disease Testing Sales by Application (2020-2025) & (K Units)
Table 38. APAC Molecular Infectious Disease Testing Sales by Region (2020-2025) & (K Units)
Table 39. APAC Molecular Infectious Disease Testing Sales Market Share by Region (2020-2025)
Table 40. APAC Molecular Infectious Disease Testing Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Molecular Infectious Disease Testing Sales by Type (2020-2025) & (K Units)
Table 42. APAC Molecular Infectious Disease Testing Sales by Application (2020-2025) & (K Units)
Table 43. Europe Molecular Infectious Disease Testing Sales by Country (2020-2025) & (K Units)
Table 44. Europe Molecular Infectious Disease Testing Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Molecular Infectious Disease Testing Sales by Type (2020-2025) & (K Units)
Table 46. Europe Molecular Infectious Disease Testing Sales by Application (2020-2025) & (K Units)
Table 47. Middle East & Africa Molecular Infectious Disease Testing Sales by Country (2020-2025) & (K Units)
Table 48. Middle East & Africa Molecular Infectious Disease Testing Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Molecular Infectious Disease Testing Sales by Type (2020-2025) & (K Units)
Table 50. Middle East & Africa Molecular Infectious Disease Testing Sales by Application (2020-2025) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Molecular Infectious Disease Testing
Table 52. Key Market Challenges & Risks of Molecular Infectious Disease Testing
Table 53. Key Industry Trends of Molecular Infectious Disease Testing
Table 54. Molecular Infectious Disease Testing Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Molecular Infectious Disease Testing Distributors List
Table 57. Molecular Infectious Disease Testing Customer List
Table 58. Global Molecular Infectious Disease Testing Sales Forecast by Region (2026-2031) & (K Units)
Table 59. Global Molecular Infectious Disease Testing Revenue Forecast by Region (2026-2031) & ($ millions)
Table 60. Americas Molecular Infectious Disease Testing Sales Forecast by Country (2026-2031) & (K Units)
Table 61. Americas Molecular Infectious Disease Testing Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 62. APAC Molecular Infectious Disease Testing Sales Forecast by Region (2026-2031) & (K Units)
Table 63. APAC Molecular Infectious Disease Testing Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Europe Molecular Infectious Disease Testing Sales Forecast by Country (2026-2031) & (K Units)
Table 65. Europe Molecular Infectious Disease Testing Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Molecular Infectious Disease Testing Sales Forecast by Country (2026-2031) & (K Units)
Table 67. Middle East & Africa Molecular Infectious Disease Testing Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Global Molecular Infectious Disease Testing Sales Forecast by Type (2026-2031) & (K Units)
Table 69. Global Molecular Infectious Disease Testing Revenue Forecast by Type (2026-2031) & ($ millions)
Table 70. Global Molecular Infectious Disease Testing Sales Forecast by Application (2026-2031) & (K Units)
Table 71. Global Molecular Infectious Disease Testing Revenue Forecast by Application (2026-2031) & ($ millions)
Table 72. Danaher Basic Information, Molecular Infectious Disease Testing Manufacturing Base, Sales Area and Its Competitors
Table 73. Danaher Molecular Infectious Disease Testing Product Portfolios and Specifications
Table 74. Danaher Molecular Infectious Disease Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 75. Danaher Main Business
Table 76. Danaher Latest Developments
Table 77. Roche Basic Information, Molecular Infectious Disease Testing Manufacturing Base, Sales Area and Its Competitors
Table 78. Roche Molecular Infectious Disease Testing Product Portfolios and Specifications
Table 79. Roche Molecular Infectious Disease Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 80. Roche Main Business
Table 81. Roche Latest Developments
Table 82. bioM?rieux Basic Information, Molecular Infectious Disease Testing Manufacturing Base, Sales Area and Its Competitors
Table 83. bioM?rieux Molecular Infectious Disease Testing Product Portfolios and Specifications
Table 84. bioM?rieux Molecular Infectious Disease Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 85. bioM?rieux Main Business
Table 86. bioM?rieux Latest Developments
Table 87. Hologic Basic Information, Molecular Infectious Disease Testing Manufacturing Base, Sales Area and Its Competitors
Table 88. Hologic Molecular Infectious Disease Testing Product Portfolios and Specifications
Table 89. Hologic Molecular Infectious Disease Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. Hologic Main Business
Table 91. Hologic Latest Developments
Table 92. Abbott Basic Information, Molecular Infectious Disease Testing Manufacturing Base, Sales Area and Its Competitors
Table 93. Abbott Molecular Infectious Disease Testing Product Portfolios and Specifications
Table 94. Abbott Molecular Infectious Disease Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 95. Abbott Main Business
Table 96. Abbott Latest Developments
Table 97. Thermo Fisher Scientific Basic Information, Molecular Infectious Disease Testing Manufacturing Base, Sales Area and Its Competitors
Table 98. Thermo Fisher Scientific Molecular Infectious Disease Testing Product Portfolios and Specifications
Table 99. Thermo Fisher Scientific Molecular Infectious Disease Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 100. Thermo Fisher Scientific Main Business
Table 101. Thermo Fisher Scientific Latest Developments
Table 102. QIAGEN Basic Information, Molecular Infectious Disease Testing Manufacturing Base, Sales Area and Its Competitors
Table 103. QIAGEN Molecular Infectious Disease Testing Product Portfolios and Specifications
Table 104. QIAGEN Molecular Infectious Disease Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 105. QIAGEN Main Business
Table 106. QIAGEN Latest Developments
Table 107. Revvity Basic Information, Molecular Infectious Disease Testing Manufacturing Base, Sales Area and Its Competitors
Table 108. Revvity Molecular Infectious Disease Testing Product Portfolios and Specifications
Table 109. Revvity Molecular Infectious Disease Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 110. Revvity Main Business
Table 111. Revvity Latest Developments
Table 112. Grifols Basic Information, Molecular Infectious Disease Testing Manufacturing Base, Sales Area and Its Competitors
Table 113. Grifols Molecular Infectious Disease Testing Product Portfolios and Specifications
Table 114. Grifols Molecular Infectious Disease Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 115. Grifols Main Business
Table 116. Grifols Latest Developments
Table 117. Seegene Basic Information, Molecular Infectious Disease Testing Manufacturing Base, Sales Area and Its Competitors
Table 118. Seegene Molecular Infectious Disease Testing Product Portfolios and Specifications
Table 119. Seegene Molecular Infectious Disease Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 120. Seegene Main Business
Table 121. Seegene Latest Developments
Table 122. DiaSorin Basic Information, Molecular Infectious Disease Testing Manufacturing Base, Sales Area and Its Competitors
Table 123. DiaSorin Molecular Infectious Disease Testing Product Portfolios and Specifications
Table 124. DiaSorin Molecular Infectious Disease Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 125. DiaSorin Main Business
Table 126. DiaSorin Latest Developments
Table 127. Siemens Healthineers Basic Information, Molecular Infectious Disease Testing Manufacturing Base, Sales Area and Its Competitors
Table 128. Siemens Healthineers Molecular Infectious Disease Testing Product Portfolios and Specifications
Table 129. Siemens Healthineers Molecular Infectious Disease Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 130. Siemens Healthineers Main Business
Table 131. Siemens Healthineers Latest Developments
Table 132. BD Basic Information, Molecular Infectious Disease Testing Manufacturing Base, Sales Area and Its Competitors
Table 133. BD Molecular Infectious Disease Testing Product Portfolios and Specifications
Table 134. BD Molecular Infectious Disease Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 135. BD Main Business
Table 136. BD Latest Developments
Table 137. QuidelOrtho Basic Information, Molecular Infectious Disease Testing Manufacturing Base, Sales Area and Its Competitors
Table 138. QuidelOrtho Molecular Infectious Disease Testing Product Portfolios and Specifications
Table 139. QuidelOrtho Molecular Infectious Disease Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 140. QuidelOrtho Main Business
Table 141. QuidelOrtho Latest Developments
Table 142. Bruker Basic Information, Molecular Infectious Disease Testing Manufacturing Base, Sales Area and Its Competitors
Table 143. Bruker Molecular Infectious Disease Testing Product Portfolios and Specifications
Table 144. Bruker Molecular Infectious Disease Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 145. Bruker Main Business
Table 146. Bruker Latest Developments
Table 147. Genetic Signatures Basic Information, Molecular Infectious Disease Testing Manufacturing Base, Sales Area and Its Competitors
Table 148. Genetic Signatures Molecular Infectious Disease Testing Product Portfolios and Specifications
Table 149. Genetic Signatures Molecular Infectious Disease Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 150. Genetic Signatures Main Business
Table 151. Genetic Signatures Latest Developments
Table 152. Co-Diagnostics Basic Information, Molecular Infectious Disease Testing Manufacturing Base, Sales Area and Its Competitors
Table 153. Co-Diagnostics Molecular Infectious Disease Testing Product Portfolios and Specifications
Table 154. Co-Diagnostics Molecular Infectious Disease Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 155. Co-Diagnostics Main Business
Table 156. Co-Diagnostics Latest Developments
Table 157. Vela Diagnostics Basic Information, Molecular Infectious Disease Testing Manufacturing Base, Sales Area and Its Competitors
Table 158. Vela Diagnostics Molecular Infectious Disease Testing Product Portfolios and Specifications
Table 159. Vela Diagnostics Molecular Infectious Disease Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 160. Vela Diagnostics Main Business
Table 161. Vela Diagnostics Latest Developments
Table 162. Molbio Diagnostics Basic Information, Molecular Infectious Disease Testing Manufacturing Base, Sales Area and Its Competitors
Table 163. Molbio Diagnostics Molecular Infectious Disease Testing Product Portfolios and Specifications
Table 164. Molbio Diagnostics Molecular Infectious Disease Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 165. Molbio Diagnostics Main Business
Table 166. Molbio Diagnostics Latest Developments
Table 167. Savyon Diagnostics Basic Information, Molecular Infectious Disease Testing Manufacturing Base, Sales Area and Its Competitors
Table 168. Savyon Diagnostics Molecular Infectious Disease Testing Product Portfolios and Specifications
Table 169. Savyon Diagnostics Molecular Infectious Disease Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 170. Savyon Diagnostics Main Business
Table 171. Savyon Diagnostics Latest Developments
Table 172. Uniogen Oy Basic Information, Molecular Infectious Disease Testing Manufacturing Base, Sales Area and Its Competitors
Table 173. Uniogen Oy Molecular Infectious Disease Testing Product Portfolios and Specifications
Table 174. Uniogen Oy Molecular Infectious Disease Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 175. Uniogen Oy Main Business
Table 176. Uniogen Oy Latest Developments
Table 177. geneOmbio Technologies Basic Information, Molecular Infectious Disease Testing Manufacturing Base, Sales Area and Its Competitors
Table 178. geneOmbio Technologies Molecular Infectious Disease Testing Product Portfolios and Specifications
Table 179. geneOmbio Technologies Molecular Infectious Disease Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 180. geneOmbio Technologies Main Business
Table 181. geneOmbio Technologies Latest Developments
Table 182. Advanced Molecular Diagnostics Basic Information, Molecular Infectious Disease Testing Manufacturing Base, Sales Area and Its Competitors
Table 183. Advanced Molecular Diagnostics Molecular Infectious Disease Testing Product Portfolios and Specifications
Table 184. Advanced Molecular Diagnostics Molecular Infectious Disease Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 185. Advanced Molecular Diagnostics Main Business
Table 186. Advanced Molecular Diagnostics Latest Developments
Table 187. altona Diagnostics Basic Information, Molecular Infectious Disease Testing Manufacturing Base, Sales Area and Its Competitors
Table 188. altona Diagnostics Molecular Infectious Disease Testing Product Portfolios and Specifications
Table 189. altona Diagnostics Molecular Infectious Disease Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 190. altona Diagnostics Main Business
Table 191. altona Diagnostics Latest Developments
Table 192. GeneFirst Basic Information, Molecular Infectious Disease Testing Manufacturing Base, Sales Area and Its Competitors
Table 193. GeneFirst Molecular Infectious Disease Testing Product Portfolios and Specifications
Table 194. GeneFirst Molecular Infectious Disease Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 195. GeneFirst Main Business
Table 196. GeneFirst Latest Developments
Table 1. Molecular Infectious Disease Testing Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Molecular Infectious Disease Testing Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Multiplex Testing
Table 4. Major Players of Singleplex Testing
Table 5. Global Molecular Infectious Disease Testing Sales by Type (2020-2025) & (K Units)
Table 6. Global Molecular Infectious Disease Testing Sales Market Share by Type (2020-2025)
Table 7. Global Molecular Infectious Disease Testing Revenue by Type (2020-2025) & ($ million)
Table 8. Global Molecular Infectious Disease Testing Revenue Market Share by Type (2020-2025)
Table 9. Global Molecular Infectious Disease Testing Sale Price by Type (2020-2025) & (US$/Unit)
Table 10. Global Molecular Infectious Disease Testing Sale by Application (2020-2025) & (K Units)
Table 11. Global Molecular Infectious Disease Testing Sale Market Share by Application (2020-2025)
Table 12. Global Molecular Infectious Disease Testing Revenue by Application (2020-2025) & ($ million)
Table 13. Global Molecular Infectious Disease Testing Revenue Market Share by Application (2020-2025)
Table 14. Global Molecular Infectious Disease Testing Sale Price by Application (2020-2025) & (US$/Unit)
Table 15. Global Molecular Infectious Disease Testing Sales by Company (2020-2025) & (K Units)
Table 16. Global Molecular Infectious Disease Testing Sales Market Share by Company (2020-2025)
Table 17. Global Molecular Infectious Disease Testing Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Molecular Infectious Disease Testing Revenue Market Share by Company (2020-2025)
Table 19. Global Molecular Infectious Disease Testing Sale Price by Company (2020-2025) & (US$/Unit)
Table 20. Key Manufacturers Molecular Infectious Disease Testing Producing Area Distribution and Sales Area
Table 21. Players Molecular Infectious Disease Testing Products Offered
Table 22. Molecular Infectious Disease Testing Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Molecular Infectious Disease Testing Sales by Geographic Region (2020-2025) & (K Units)
Table 26. Global Molecular Infectious Disease Testing Sales Market Share Geographic Region (2020-2025)
Table 27. Global Molecular Infectious Disease Testing Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Molecular Infectious Disease Testing Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Molecular Infectious Disease Testing Sales by Country/Region (2020-2025) & (K Units)
Table 30. Global Molecular Infectious Disease Testing Sales Market Share by Country/Region (2020-2025)
Table 31. Global Molecular Infectious Disease Testing Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Molecular Infectious Disease Testing Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Molecular Infectious Disease Testing Sales by Country (2020-2025) & (K Units)
Table 34. Americas Molecular Infectious Disease Testing Sales Market Share by Country (2020-2025)
Table 35. Americas Molecular Infectious Disease Testing Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Molecular Infectious Disease Testing Sales by Type (2020-2025) & (K Units)
Table 37. Americas Molecular Infectious Disease Testing Sales by Application (2020-2025) & (K Units)
Table 38. APAC Molecular Infectious Disease Testing Sales by Region (2020-2025) & (K Units)
Table 39. APAC Molecular Infectious Disease Testing Sales Market Share by Region (2020-2025)
Table 40. APAC Molecular Infectious Disease Testing Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Molecular Infectious Disease Testing Sales by Type (2020-2025) & (K Units)
Table 42. APAC Molecular Infectious Disease Testing Sales by Application (2020-2025) & (K Units)
Table 43. Europe Molecular Infectious Disease Testing Sales by Country (2020-2025) & (K Units)
Table 44. Europe Molecular Infectious Disease Testing Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Molecular Infectious Disease Testing Sales by Type (2020-2025) & (K Units)
Table 46. Europe Molecular Infectious Disease Testing Sales by Application (2020-2025) & (K Units)
Table 47. Middle East & Africa Molecular Infectious Disease Testing Sales by Country (2020-2025) & (K Units)
Table 48. Middle East & Africa Molecular Infectious Disease Testing Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Molecular Infectious Disease Testing Sales by Type (2020-2025) & (K Units)
Table 50. Middle East & Africa Molecular Infectious Disease Testing Sales by Application (2020-2025) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Molecular Infectious Disease Testing
Table 52. Key Market Challenges & Risks of Molecular Infectious Disease Testing
Table 53. Key Industry Trends of Molecular Infectious Disease Testing
Table 54. Molecular Infectious Disease Testing Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Molecular Infectious Disease Testing Distributors List
Table 57. Molecular Infectious Disease Testing Customer List
Table 58. Global Molecular Infectious Disease Testing Sales Forecast by Region (2026-2031) & (K Units)
Table 59. Global Molecular Infectious Disease Testing Revenue Forecast by Region (2026-2031) & ($ millions)
Table 60. Americas Molecular Infectious Disease Testing Sales Forecast by Country (2026-2031) & (K Units)
Table 61. Americas Molecular Infectious Disease Testing Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 62. APAC Molecular Infectious Disease Testing Sales Forecast by Region (2026-2031) & (K Units)
Table 63. APAC Molecular Infectious Disease Testing Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Europe Molecular Infectious Disease Testing Sales Forecast by Country (2026-2031) & (K Units)
Table 65. Europe Molecular Infectious Disease Testing Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Molecular Infectious Disease Testing Sales Forecast by Country (2026-2031) & (K Units)
Table 67. Middle East & Africa Molecular Infectious Disease Testing Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Global Molecular Infectious Disease Testing Sales Forecast by Type (2026-2031) & (K Units)
Table 69. Global Molecular Infectious Disease Testing Revenue Forecast by Type (2026-2031) & ($ millions)
Table 70. Global Molecular Infectious Disease Testing Sales Forecast by Application (2026-2031) & (K Units)
Table 71. Global Molecular Infectious Disease Testing Revenue Forecast by Application (2026-2031) & ($ millions)
Table 72. Danaher Basic Information, Molecular Infectious Disease Testing Manufacturing Base, Sales Area and Its Competitors
Table 73. Danaher Molecular Infectious Disease Testing Product Portfolios and Specifications
Table 74. Danaher Molecular Infectious Disease Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 75. Danaher Main Business
Table 76. Danaher Latest Developments
Table 77. Roche Basic Information, Molecular Infectious Disease Testing Manufacturing Base, Sales Area and Its Competitors
Table 78. Roche Molecular Infectious Disease Testing Product Portfolios and Specifications
Table 79. Roche Molecular Infectious Disease Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 80. Roche Main Business
Table 81. Roche Latest Developments
Table 82. bioM?rieux Basic Information, Molecular Infectious Disease Testing Manufacturing Base, Sales Area and Its Competitors
Table 83. bioM?rieux Molecular Infectious Disease Testing Product Portfolios and Specifications
Table 84. bioM?rieux Molecular Infectious Disease Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 85. bioM?rieux Main Business
Table 86. bioM?rieux Latest Developments
Table 87. Hologic Basic Information, Molecular Infectious Disease Testing Manufacturing Base, Sales Area and Its Competitors
Table 88. Hologic Molecular Infectious Disease Testing Product Portfolios and Specifications
Table 89. Hologic Molecular Infectious Disease Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. Hologic Main Business
Table 91. Hologic Latest Developments
Table 92. Abbott Basic Information, Molecular Infectious Disease Testing Manufacturing Base, Sales Area and Its Competitors
Table 93. Abbott Molecular Infectious Disease Testing Product Portfolios and Specifications
Table 94. Abbott Molecular Infectious Disease Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 95. Abbott Main Business
Table 96. Abbott Latest Developments
Table 97. Thermo Fisher Scientific Basic Information, Molecular Infectious Disease Testing Manufacturing Base, Sales Area and Its Competitors
Table 98. Thermo Fisher Scientific Molecular Infectious Disease Testing Product Portfolios and Specifications
Table 99. Thermo Fisher Scientific Molecular Infectious Disease Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 100. Thermo Fisher Scientific Main Business
Table 101. Thermo Fisher Scientific Latest Developments
Table 102. QIAGEN Basic Information, Molecular Infectious Disease Testing Manufacturing Base, Sales Area and Its Competitors
Table 103. QIAGEN Molecular Infectious Disease Testing Product Portfolios and Specifications
Table 104. QIAGEN Molecular Infectious Disease Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 105. QIAGEN Main Business
Table 106. QIAGEN Latest Developments
Table 107. Revvity Basic Information, Molecular Infectious Disease Testing Manufacturing Base, Sales Area and Its Competitors
Table 108. Revvity Molecular Infectious Disease Testing Product Portfolios and Specifications
Table 109. Revvity Molecular Infectious Disease Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 110. Revvity Main Business
Table 111. Revvity Latest Developments
Table 112. Grifols Basic Information, Molecular Infectious Disease Testing Manufacturing Base, Sales Area and Its Competitors
Table 113. Grifols Molecular Infectious Disease Testing Product Portfolios and Specifications
Table 114. Grifols Molecular Infectious Disease Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 115. Grifols Main Business
Table 116. Grifols Latest Developments
Table 117. Seegene Basic Information, Molecular Infectious Disease Testing Manufacturing Base, Sales Area and Its Competitors
Table 118. Seegene Molecular Infectious Disease Testing Product Portfolios and Specifications
Table 119. Seegene Molecular Infectious Disease Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 120. Seegene Main Business
Table 121. Seegene Latest Developments
Table 122. DiaSorin Basic Information, Molecular Infectious Disease Testing Manufacturing Base, Sales Area and Its Competitors
Table 123. DiaSorin Molecular Infectious Disease Testing Product Portfolios and Specifications
Table 124. DiaSorin Molecular Infectious Disease Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 125. DiaSorin Main Business
Table 126. DiaSorin Latest Developments
Table 127. Siemens Healthineers Basic Information, Molecular Infectious Disease Testing Manufacturing Base, Sales Area and Its Competitors
Table 128. Siemens Healthineers Molecular Infectious Disease Testing Product Portfolios and Specifications
Table 129. Siemens Healthineers Molecular Infectious Disease Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 130. Siemens Healthineers Main Business
Table 131. Siemens Healthineers Latest Developments
Table 132. BD Basic Information, Molecular Infectious Disease Testing Manufacturing Base, Sales Area and Its Competitors
Table 133. BD Molecular Infectious Disease Testing Product Portfolios and Specifications
Table 134. BD Molecular Infectious Disease Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 135. BD Main Business
Table 136. BD Latest Developments
Table 137. QuidelOrtho Basic Information, Molecular Infectious Disease Testing Manufacturing Base, Sales Area and Its Competitors
Table 138. QuidelOrtho Molecular Infectious Disease Testing Product Portfolios and Specifications
Table 139. QuidelOrtho Molecular Infectious Disease Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 140. QuidelOrtho Main Business
Table 141. QuidelOrtho Latest Developments
Table 142. Bruker Basic Information, Molecular Infectious Disease Testing Manufacturing Base, Sales Area and Its Competitors
Table 143. Bruker Molecular Infectious Disease Testing Product Portfolios and Specifications
Table 144. Bruker Molecular Infectious Disease Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 145. Bruker Main Business
Table 146. Bruker Latest Developments
Table 147. Genetic Signatures Basic Information, Molecular Infectious Disease Testing Manufacturing Base, Sales Area and Its Competitors
Table 148. Genetic Signatures Molecular Infectious Disease Testing Product Portfolios and Specifications
Table 149. Genetic Signatures Molecular Infectious Disease Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 150. Genetic Signatures Main Business
Table 151. Genetic Signatures Latest Developments
Table 152. Co-Diagnostics Basic Information, Molecular Infectious Disease Testing Manufacturing Base, Sales Area and Its Competitors
Table 153. Co-Diagnostics Molecular Infectious Disease Testing Product Portfolios and Specifications
Table 154. Co-Diagnostics Molecular Infectious Disease Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 155. Co-Diagnostics Main Business
Table 156. Co-Diagnostics Latest Developments
Table 157. Vela Diagnostics Basic Information, Molecular Infectious Disease Testing Manufacturing Base, Sales Area and Its Competitors
Table 158. Vela Diagnostics Molecular Infectious Disease Testing Product Portfolios and Specifications
Table 159. Vela Diagnostics Molecular Infectious Disease Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 160. Vela Diagnostics Main Business
Table 161. Vela Diagnostics Latest Developments
Table 162. Molbio Diagnostics Basic Information, Molecular Infectious Disease Testing Manufacturing Base, Sales Area and Its Competitors
Table 163. Molbio Diagnostics Molecular Infectious Disease Testing Product Portfolios and Specifications
Table 164. Molbio Diagnostics Molecular Infectious Disease Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 165. Molbio Diagnostics Main Business
Table 166. Molbio Diagnostics Latest Developments
Table 167. Savyon Diagnostics Basic Information, Molecular Infectious Disease Testing Manufacturing Base, Sales Area and Its Competitors
Table 168. Savyon Diagnostics Molecular Infectious Disease Testing Product Portfolios and Specifications
Table 169. Savyon Diagnostics Molecular Infectious Disease Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 170. Savyon Diagnostics Main Business
Table 171. Savyon Diagnostics Latest Developments
Table 172. Uniogen Oy Basic Information, Molecular Infectious Disease Testing Manufacturing Base, Sales Area and Its Competitors
Table 173. Uniogen Oy Molecular Infectious Disease Testing Product Portfolios and Specifications
Table 174. Uniogen Oy Molecular Infectious Disease Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 175. Uniogen Oy Main Business
Table 176. Uniogen Oy Latest Developments
Table 177. geneOmbio Technologies Basic Information, Molecular Infectious Disease Testing Manufacturing Base, Sales Area and Its Competitors
Table 178. geneOmbio Technologies Molecular Infectious Disease Testing Product Portfolios and Specifications
Table 179. geneOmbio Technologies Molecular Infectious Disease Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 180. geneOmbio Technologies Main Business
Table 181. geneOmbio Technologies Latest Developments
Table 182. Advanced Molecular Diagnostics Basic Information, Molecular Infectious Disease Testing Manufacturing Base, Sales Area and Its Competitors
Table 183. Advanced Molecular Diagnostics Molecular Infectious Disease Testing Product Portfolios and Specifications
Table 184. Advanced Molecular Diagnostics Molecular Infectious Disease Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 185. Advanced Molecular Diagnostics Main Business
Table 186. Advanced Molecular Diagnostics Latest Developments
Table 187. altona Diagnostics Basic Information, Molecular Infectious Disease Testing Manufacturing Base, Sales Area and Its Competitors
Table 188. altona Diagnostics Molecular Infectious Disease Testing Product Portfolios and Specifications
Table 189. altona Diagnostics Molecular Infectious Disease Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 190. altona Diagnostics Main Business
Table 191. altona Diagnostics Latest Developments
Table 192. GeneFirst Basic Information, Molecular Infectious Disease Testing Manufacturing Base, Sales Area and Its Competitors
Table 193. GeneFirst Molecular Infectious Disease Testing Product Portfolios and Specifications
Table 194. GeneFirst Molecular Infectious Disease Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 195. GeneFirst Main Business
Table 196. GeneFirst Latest Developments
LIST OF FIGURES
Figure 1. Picture of Molecular Infectious Disease Testing
Figure 2. Molecular Infectious Disease Testing Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Molecular Infectious Disease Testing Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Molecular Infectious Disease Testing Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Molecular Infectious Disease Testing Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Molecular Infectious Disease Testing Sales Market Share by Country/Region (2024)
Figure 10. Molecular Infectious Disease Testing Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Multiplex Testing
Figure 12. Product Picture of Singleplex Testing
Figure 13. Global Molecular Infectious Disease Testing Sales Market Share by Type in 2025
Figure 14. Global Molecular Infectious Disease Testing Revenue Market Share by Type (2020-2025)
Figure 15. Molecular Infectious Disease Testing Consumed in Diagnostic Laboratories
Figure 16. Global Molecular Infectious Disease Testing Market: Diagnostic Laboratories (2020-2025) & (K Units)
Figure 17. Molecular Infectious Disease Testing Consumed in Hospitals and Clinics
Figure 18. Global Molecular Infectious Disease Testing Market: Hospitals and Clinics (2020-2025) & (K Units)
Figure 19. Molecular Infectious Disease Testing Consumed in Others
Figure 20. Global Molecular Infectious Disease Testing Market: Others (2020-2025) & (K Units)
Figure 21. Global Molecular Infectious Disease Testing Sale Market Share by Application (2024)
Figure 22. Global Molecular Infectious Disease Testing Revenue Market Share by Application in 2025
Figure 23. Molecular Infectious Disease Testing Sales by Company in 2025 (K Units)
Figure 24. Global Molecular Infectious Disease Testing Sales Market Share by Company in 2025
Figure 25. Molecular Infectious Disease Testing Revenue by Company in 2025 ($ millions)
Figure 26. Global Molecular Infectious Disease Testing Revenue Market Share by Company in 2025
Figure 27. Global Molecular Infectious Disease Testing Sales Market Share by Geographic Region (2020-2025)
Figure 28. Global Molecular Infectious Disease Testing Revenue Market Share by Geographic Region in 2025
Figure 29. Americas Molecular Infectious Disease Testing Sales 2020-2025 (K Units)
Figure 30. Americas Molecular Infectious Disease Testing Revenue 2020-2025 ($ millions)
Figure 31. APAC Molecular Infectious Disease Testing Sales 2020-2025 (K Units)
Figure 32. APAC Molecular Infectious Disease Testing Revenue 2020-2025 ($ millions)
Figure 33. Europe Molecular Infectious Disease Testing Sales 2020-2025 (K Units)
Figure 34. Europe Molecular Infectious Disease Testing Revenue 2020-2025 ($ millions)
Figure 35. Middle East & Africa Molecular Infectious Disease Testing Sales 2020-2025 (K Units)
Figure 36. Middle East & Africa Molecular Infectious Disease Testing Revenue 2020-2025 ($ millions)
Figure 37. Americas Molecular Infectious Disease Testing Sales Market Share by Country in 2025
Figure 38. Americas Molecular Infectious Disease Testing Revenue Market Share by Country (2020-2025)
Figure 39. Americas Molecular Infectious Disease Testing Sales Market Share by Type (2020-2025)
Figure 40. Americas Molecular Infectious Disease Testing Sales Market Share by Application (2020-2025)
Figure 41. United States Molecular Infectious Disease Testing Revenue Growth 2020-2025 ($ millions)
Figure 42. Canada Molecular Infectious Disease Testing Revenue Growth 2020-2025 ($ millions)
Figure 43. Mexico Molecular Infectious Disease Testing Revenue Growth 2020-2025 ($ millions)
Figure 44. Brazil Molecular Infectious Disease Testing Revenue Growth 2020-2025 ($ millions)
Figure 45. APAC Molecular Infectious Disease Testing Sales Market Share by Region in 2025
Figure 46. APAC Molecular Infectious Disease Testing Revenue Market Share by Region (2020-2025)
Figure 47. APAC Molecular Infectious Disease Testing Sales Market Share by Type (2020-2025)
Figure 48. APAC Molecular Infectious Disease Testing Sales Market Share by Application (2020-2025)
Figure 49. China Molecular Infectious Disease Testing Revenue Growth 2020-2025 ($ millions)
Figure 50. Japan Molecular Infectious Disease Testing Revenue Growth 2020-2025 ($ millions)
Figure 51. South Korea Molecular Infectious Disease Testing Revenue Growth 2020-2025 ($ millions)
Figure 52. Southeast Asia Molecular Infectious Disease Testing Revenue Growth 2020-2025 ($ millions)
Figure 53. India Molecular Infectious Disease Testing Revenue Growth 2020-2025 ($ millions)
Figure 54. Australia Molecular Infectious Disease Testing Revenue Growth 2020-2025 ($ millions)
Figure 55. China Taiwan Molecular Infectious Disease Testing Revenue Growth 2020-2025 ($ millions)
Figure 56. Europe Molecular Infectious Disease Testing Sales Market Share by Country in 2025
Figure 57. Europe Molecular Infectious Disease Testing Revenue Market Share by Country (2020-2025)
Figure 58. Europe Molecular Infectious Disease Testing Sales Market Share by Type (2020-2025)
Figure 59. Europe Molecular Infectious Disease Testing Sales Market Share by Application (2020-2025)
Figure 60. Germany Molecular Infectious Disease Testing Revenue Growth 2020-2025 ($ millions)
Figure 61. France Molecular Infectious Disease Testing Revenue Growth 2020-2025 ($ millions)
Figure 62. UK Molecular Infectious Disease Testing Revenue Growth 2020-2025 ($ millions)
Figure 63. Italy Molecular Infectious Disease Testing Revenue Growth 2020-2025 ($ millions)
Figure 64. Russia Molecular Infectious Disease Testing Revenue Growth 2020-2025 ($ millions)
Figure 65. Middle East & Africa Molecular Infectious Disease Testing Sales Market Share by Country (2020-2025)
Figure 66. Middle East & Africa Molecular Infectious Disease Testing Sales Market Share by Type (2020-2025)
Figure 67. Middle East & Africa Molecular Infectious Disease Testing Sales Market Share by Application (2020-2025)
Figure 68. Egypt Molecular Infectious Disease Testing Revenue Growth 2020-2025 ($ millions)
Figure 69. South Africa Molecular Infectious Disease Testing Revenue Growth 2020-2025 ($ millions)
Figure 70. Israel Molecular Infectious Disease Testing Revenue Growth 2020-2025 ($ millions)
Figure 71. Turkey Molecular Infectious Disease Testing Revenue Growth 2020-2025 ($ millions)
Figure 72. GCC Countries Molecular Infectious Disease Testing Revenue Growth 2020-2025 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Molecular Infectious Disease Testing in 2025
Figure 74. Manufacturing Process Analysis of Molecular Infectious Disease Testing
Figure 75. Industry Chain Structure of Molecular Infectious Disease Testing
Figure 76. Channels of Distribution
Figure 77. Global Molecular Infectious Disease Testing Sales Market Forecast by Region (2026-2031)
Figure 78. Global Molecular Infectious Disease Testing Revenue Market Share Forecast by Region (2026-2031)
Figure 79. Global Molecular Infectious Disease Testing Sales Market Share Forecast by Type (2026-2031)
Figure 80. Global Molecular Infectious Disease Testing Revenue Market Share Forecast by Type (2026-2031)
Figure 81. Global Molecular Infectious Disease Testing Sales Market Share Forecast by Application (2026-2031)
Figure 82. Global Molecular Infectious Disease Testing Revenue Market Share Forecast by Application (2026-2031)
Figure 1. Picture of Molecular Infectious Disease Testing
Figure 2. Molecular Infectious Disease Testing Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Molecular Infectious Disease Testing Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Molecular Infectious Disease Testing Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Molecular Infectious Disease Testing Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Molecular Infectious Disease Testing Sales Market Share by Country/Region (2024)
Figure 10. Molecular Infectious Disease Testing Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Multiplex Testing
Figure 12. Product Picture of Singleplex Testing
Figure 13. Global Molecular Infectious Disease Testing Sales Market Share by Type in 2025
Figure 14. Global Molecular Infectious Disease Testing Revenue Market Share by Type (2020-2025)
Figure 15. Molecular Infectious Disease Testing Consumed in Diagnostic Laboratories
Figure 16. Global Molecular Infectious Disease Testing Market: Diagnostic Laboratories (2020-2025) & (K Units)
Figure 17. Molecular Infectious Disease Testing Consumed in Hospitals and Clinics
Figure 18. Global Molecular Infectious Disease Testing Market: Hospitals and Clinics (2020-2025) & (K Units)
Figure 19. Molecular Infectious Disease Testing Consumed in Others
Figure 20. Global Molecular Infectious Disease Testing Market: Others (2020-2025) & (K Units)
Figure 21. Global Molecular Infectious Disease Testing Sale Market Share by Application (2024)
Figure 22. Global Molecular Infectious Disease Testing Revenue Market Share by Application in 2025
Figure 23. Molecular Infectious Disease Testing Sales by Company in 2025 (K Units)
Figure 24. Global Molecular Infectious Disease Testing Sales Market Share by Company in 2025
Figure 25. Molecular Infectious Disease Testing Revenue by Company in 2025 ($ millions)
Figure 26. Global Molecular Infectious Disease Testing Revenue Market Share by Company in 2025
Figure 27. Global Molecular Infectious Disease Testing Sales Market Share by Geographic Region (2020-2025)
Figure 28. Global Molecular Infectious Disease Testing Revenue Market Share by Geographic Region in 2025
Figure 29. Americas Molecular Infectious Disease Testing Sales 2020-2025 (K Units)
Figure 30. Americas Molecular Infectious Disease Testing Revenue 2020-2025 ($ millions)
Figure 31. APAC Molecular Infectious Disease Testing Sales 2020-2025 (K Units)
Figure 32. APAC Molecular Infectious Disease Testing Revenue 2020-2025 ($ millions)
Figure 33. Europe Molecular Infectious Disease Testing Sales 2020-2025 (K Units)
Figure 34. Europe Molecular Infectious Disease Testing Revenue 2020-2025 ($ millions)
Figure 35. Middle East & Africa Molecular Infectious Disease Testing Sales 2020-2025 (K Units)
Figure 36. Middle East & Africa Molecular Infectious Disease Testing Revenue 2020-2025 ($ millions)
Figure 37. Americas Molecular Infectious Disease Testing Sales Market Share by Country in 2025
Figure 38. Americas Molecular Infectious Disease Testing Revenue Market Share by Country (2020-2025)
Figure 39. Americas Molecular Infectious Disease Testing Sales Market Share by Type (2020-2025)
Figure 40. Americas Molecular Infectious Disease Testing Sales Market Share by Application (2020-2025)
Figure 41. United States Molecular Infectious Disease Testing Revenue Growth 2020-2025 ($ millions)
Figure 42. Canada Molecular Infectious Disease Testing Revenue Growth 2020-2025 ($ millions)
Figure 43. Mexico Molecular Infectious Disease Testing Revenue Growth 2020-2025 ($ millions)
Figure 44. Brazil Molecular Infectious Disease Testing Revenue Growth 2020-2025 ($ millions)
Figure 45. APAC Molecular Infectious Disease Testing Sales Market Share by Region in 2025
Figure 46. APAC Molecular Infectious Disease Testing Revenue Market Share by Region (2020-2025)
Figure 47. APAC Molecular Infectious Disease Testing Sales Market Share by Type (2020-2025)
Figure 48. APAC Molecular Infectious Disease Testing Sales Market Share by Application (2020-2025)
Figure 49. China Molecular Infectious Disease Testing Revenue Growth 2020-2025 ($ millions)
Figure 50. Japan Molecular Infectious Disease Testing Revenue Growth 2020-2025 ($ millions)
Figure 51. South Korea Molecular Infectious Disease Testing Revenue Growth 2020-2025 ($ millions)
Figure 52. Southeast Asia Molecular Infectious Disease Testing Revenue Growth 2020-2025 ($ millions)
Figure 53. India Molecular Infectious Disease Testing Revenue Growth 2020-2025 ($ millions)
Figure 54. Australia Molecular Infectious Disease Testing Revenue Growth 2020-2025 ($ millions)
Figure 55. China Taiwan Molecular Infectious Disease Testing Revenue Growth 2020-2025 ($ millions)
Figure 56. Europe Molecular Infectious Disease Testing Sales Market Share by Country in 2025
Figure 57. Europe Molecular Infectious Disease Testing Revenue Market Share by Country (2020-2025)
Figure 58. Europe Molecular Infectious Disease Testing Sales Market Share by Type (2020-2025)
Figure 59. Europe Molecular Infectious Disease Testing Sales Market Share by Application (2020-2025)
Figure 60. Germany Molecular Infectious Disease Testing Revenue Growth 2020-2025 ($ millions)
Figure 61. France Molecular Infectious Disease Testing Revenue Growth 2020-2025 ($ millions)
Figure 62. UK Molecular Infectious Disease Testing Revenue Growth 2020-2025 ($ millions)
Figure 63. Italy Molecular Infectious Disease Testing Revenue Growth 2020-2025 ($ millions)
Figure 64. Russia Molecular Infectious Disease Testing Revenue Growth 2020-2025 ($ millions)
Figure 65. Middle East & Africa Molecular Infectious Disease Testing Sales Market Share by Country (2020-2025)
Figure 66. Middle East & Africa Molecular Infectious Disease Testing Sales Market Share by Type (2020-2025)
Figure 67. Middle East & Africa Molecular Infectious Disease Testing Sales Market Share by Application (2020-2025)
Figure 68. Egypt Molecular Infectious Disease Testing Revenue Growth 2020-2025 ($ millions)
Figure 69. South Africa Molecular Infectious Disease Testing Revenue Growth 2020-2025 ($ millions)
Figure 70. Israel Molecular Infectious Disease Testing Revenue Growth 2020-2025 ($ millions)
Figure 71. Turkey Molecular Infectious Disease Testing Revenue Growth 2020-2025 ($ millions)
Figure 72. GCC Countries Molecular Infectious Disease Testing Revenue Growth 2020-2025 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Molecular Infectious Disease Testing in 2025
Figure 74. Manufacturing Process Analysis of Molecular Infectious Disease Testing
Figure 75. Industry Chain Structure of Molecular Infectious Disease Testing
Figure 76. Channels of Distribution
Figure 77. Global Molecular Infectious Disease Testing Sales Market Forecast by Region (2026-2031)
Figure 78. Global Molecular Infectious Disease Testing Revenue Market Share Forecast by Region (2026-2031)
Figure 79. Global Molecular Infectious Disease Testing Sales Market Share Forecast by Type (2026-2031)
Figure 80. Global Molecular Infectious Disease Testing Revenue Market Share Forecast by Type (2026-2031)
Figure 81. Global Molecular Infectious Disease Testing Sales Market Share Forecast by Application (2026-2031)
Figure 82. Global Molecular Infectious Disease Testing Revenue Market Share Forecast by Application (2026-2031)